Chongqing Taiji Industry Group Co Ltd. Stock Analysis 600129.SS

Chongqing Taiji Industry (Group) Co., Ltd. engages in the processing, production and distribution of Chinese patent medicines and health care products. The company is headquartered in Chongqing, Chongqing and currently employs 10,864 full-time employees. The firm operates four segments. Pharmaceutical Industry segment mainly produces Chinese patent medicines and Western medicines. Pharmaceutical Business segment mainly includes pharmaceutical distribution and retail. The firm also operates Chinese herbal medicine resource segment and Service and Other segment. The firm's products include digestive system and metabolic drugs, respiratory system drugs, cardiovascular and cerebrovascular drugs, anti-infective drugs, nervous system drugs, anti-tumor and immune regulation drugs, and health products. The firm mainly operates its businesses in the domestic market.